Predictors of mortality among HIV-infected patients initiating anti retroviral therapy at a tertiary care hospital in Eastern India

Asian Pacific Journal of Tropical Medicine

Volumn 5, Issue 12, 2012, Pages 986-990

  Bhowmik, Ananya ^a   Bhandari, Subhasis ^a   De, Rajyasree ^a   Guha, Subhasish Kamal ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

Albumin; ART; CD4; HIV; India; Mortality; Predictors

Indexed keywords

ALBUMIN; ANTIRETROVIRUS AGENT; NEVIRAPINE;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTIRETROVIRAL THERAPY; ARTICLE; BRAIN DISEASE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CRYPTOCOCCAL MENINGITIS; DIARRHEA; DRUG ERUPTION; DRUG THERAPY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPTICEMIA; TERTIARY HEALTH CARE; TOXOPLASMOSIS;

ADOLESCENT; ADULT; AGED; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY HEALTHCARE; TUBERCULOSIS;

EID: 84872368727     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60187-4     Document Type: Article

References (27)

1. United Nations Millennium Declaration United Nations, 2000. [Online] [Accessed on January 10, 2011]. http://www.un.org/millenniumgoals/aids.shtml.
2. WHO, UNICEF, UNAIDS Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010. Geneva, World Health Organization, 2010. [Online] [Accessed on 10 January 2011]. http://www.who.int/hiv/pub/2010progressreport/report/en/index.html.
3. WHO Global report: UNAIDS report on the global AIDS epidemic 2010. Joint United Nations Programme on HIV/AIDS (UNAIDS) 2010. [Online] [Accessed on June 10, 2011]. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/20101123_globalreport_en.pdf.
4. Ivers LC, Kendrick D, Doucette K Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 2005, 41:217-224.
5. National AIDS Control Organization of India Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis. NACO 2007. [Online] [Accessed 10 January 2011]. http://www.whoindia.org/en/Section3/Section125_1499.htm.
6. Girardi E, Sabin CA, Monforte AD Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007, 46(Suppl 1):S3-S8.
7. Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, Wood R Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 2006, 43(6):770-776.
8. Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 2008, 22(8):52-62.
9. Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, et al. Risk factors for high early mortality in patients on antiretroviral reatment in a rural district of Malawi. AIDS 2006, 20(18):2355-2360.
10. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006, 296(7):782-793.
11. The antiretroviral therapy in lower income countries (ART-Linc) collaboration, ART cohort collaboration (ART-CC) groups Mortality of HIV-1 infected patients in the first year of antiretroviral therapy: Comparison between low-income and high income countries. Lancet 2006, 367(9513):817-824.
12. Bachani D, Garg R, Rewari BB, Hegg L, Rajasekaran S, Deshpande A, et al. Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme. Natl Med J India 2010, 23(1):7-12.
13. Paton NI, Sangeetha S, Earnest A, Bellamy R The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy. HIV Med 2006, 7(5):323-330.
14. Asgeir J, Ezra N, Bernard JN, Leiv S, Mecky IM, Henry EA, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 2008, 8:52-56.
15. Etard JF, Ndiaye I, Thierry-Mieg M, Guèye NF, Guèye PM, Lanièce I, et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 2006, 20(8):1181-1189.
16. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005, 19(18):2141-2148.
17. Ghate M, Deshpande S, Tripathy S, Godbole S, Nene M, Thakar M, et al. Mortality in HIV infected individuals in Pune, India. Indian J Med Res 2011, 133(4):414-420.
18. Feldman JG, Burns DN, Gange SJ, Bacchetti P, Cohen M, Anastos K, et al. Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV Study. AIDS 2000, 14(7):863-870.
19. Ward T, Powell RM, Evans DJ, Almond JW Serum albumin inhibits echovirus 7 uncoating. J Gen Virol 1999, 80(Pt2):283-290.
20. Kuipers ME, Berg M, Swart PJ, Laman JD, Meijer DK, Koppelman MH, et al. Mechanism of anti-HIV activity of succinylated human serum albumin. Biochem Pharmacol 1999, 57(8):889-898.
21. Oshima T, Flores SC, Gisela V, Coe LL, Joh T, Park JH, et al. HIV-1 TAT increases endothelial solute permeability through tyrosine kinase and mitogenactivated protein kinase-dependent pathways. AIDS 2000, 14(5):475-482.
22. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF Preoperative serum albumin level as a predictor of operative mortality and morbidity, Results from the national VA surgical risk study. Arch Surg 1999, 134(1):36-42.
23. Ramakrishnan K, Shenbagarathai R, Kavitha K, Uma A, Balasubramaniam R, Thirumalaikolundusubramanian P Serum zinc and albumin levels in pulmonary tuberculosis patients with and without HIV. Jpn J Infect Dis 2008, 61(3):202-204.
24. Sundaram M, Srinivas CM, Shankar EM Cofactors for low serum albumin levels among HIV-infected individuals in southern India. J Int Assoc Physicians AIDS Care 2009, 8(3):161-164.
25. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006, 367(9519):1335-1342.
26. Wester CW, Kim S, Bussmann H, Avalos A, Ndwapi N, Peter TF, et al. Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr 2005, 40(3):336-343.
27. Mzileni MO, Longo-Mbenza B, Chephe TJ Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital. Pol Arch Med Wewn 2008, 118(10):548-554.